Download PDF
Am J Perinatol 2018; 35(04): 369-379
DOI: 10.1055/s-0037-1607347
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Plasma Lipoprotein Particle Subclasses in Preterm Infants

Jennifer A. Scoble
1   Department of Pediatrics, UC Davis School of Medicine, Sacramento, California
,
Jennifer T. Smilowitz
2   Department of Food Science and Technology, University of California, Davis, California
3   Foods for Health Institute, University of California, Davis, California
,
Nurit Argov-Argaman
4   Department of Animal Science, The Robert H. Smith Faculty of Agriculture, Food, and Environment, The Hebrew University of Jerusalem, Jerusalem, Israel
,
J. Bruce German
2   Department of Food Science and Technology, University of California, Davis, California
3   Foods for Health Institute, University of California, Davis, California
,
Mark A. Underwood
1   Department of Pediatrics, UC Davis School of Medicine, Sacramento, California
3   Foods for Health Institute, University of California, Davis, California
› Author Affiliations Funding This study was funded in part by a grant to Dr Scoble from the Clinical Translational Science Center at UC Davis through the Mentored Clinical Research Training Program (National Center for Advancing Translational Sciences, National Institutes of Health, through grant no. UL1 TR000002).
Further Information

Publication History

07 June 2017

14 September 2017

Publication Date:
26 October 2017 (online)

    Permissions and Reprints

Abstract

Objective A pilot study to determine lipoprotein classes and subclasses in premature infants and examine associations with nutritional intake, gestational age (GA), and morbidity.

Study Design Plasma lipoprotein particle concentrations were analyzed in a cohort of 15 premature infants in the first 5 days of life and again at 2 weeks. Breast milk samples were analyzed for fatty acid content. Associations between lipoprotein particle subclasses and GA, breast milk intake, milk fatty acid intake, and chronic lung disease (CLD) were determined.

Results At 2 weeks of age, more premature infants had higher concentrations of total very low-density lipoprotein and lower concentrations of total high-density lipoprotein (HDL) and large HDL particles (similar to profiles seen in adults and children with infectious disease, cardiometabolic disease, and diabetes). Lower total HDL, large HDL, and medium HDL and a higher small HDL:total HDL ratio at 2 weeks were each associated with CLD with GA a likely confounder. Intake of human milk C18 and C20 fatty acids was inversely correlated with plasma total LDL concentration at 2 weeks of age.

Conclusion Dyslipidemia was common in extremely premature infants and was associated with CLD and with lower intake of specific long chain fatty acids.

Keywords

high-density lipoprotein - low-density lipoprotein - very low-density lipoprotein - chronic lung disease - human milk - premature infant - fatty acid
 

  • References

  • 1 de Jong M, Cranendonk A, van Weissenbruch MM. Components of the metabolic syndrome in early childhood in very-low-birth-weight infants and term small and appropriate for gestational age infants. Pediatr Res 2015; 78 (04) 457-461
    CrossrefPubMedGoogle Scholar
  • 2 Breukhoven PE, Kerkhof GF, Willemsen RH, Hokken-Koelega AC. Fat mass and lipid profile in young adults born preterm. J Clin Endocrinol Metab 2012; 97 (04) 1294-1302
    CrossrefPubMedGoogle Scholar
  • 3 van Bergenhenegouwen J, Kraneveld AD, Rutten L, Garssen J, Vos AP, Hartog A. Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics. BMC Immunol 2016; 17 DOI: 10.1186/s12865-016-0180-x.
    CrossrefPubMedGoogle Scholar
  • 4 Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18 (07) 1046-1053
    CrossrefPubMedGoogle Scholar
  • 5 Mekki N, Charbonnier M, Borel P. , et al. Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr 2002; 132 (12) 3642-3649
    CrossrefPubMedGoogle Scholar
  • 6 Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003; 46 (06) 733-749
    CrossrefPubMedGoogle Scholar
  • 7 Orimadegun AE, Orimadegun BE. Serum apolipoprotein-A1 and cholesterol levels in Nigerian children with Plasmodium falciparum infection. Med Princ Pract 2015; 24 (04) 318-324
    CrossrefPubMedGoogle Scholar
  • 8 Suvarna JC, Rane PP. Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop Med Int Health 2009; 14 (05) 576-585
    CrossrefPubMedGoogle Scholar
  • 9 Yildiz B, Ucar B, Aksit A, Aydogdu SD, Colak O, Colak E. Diagnostic values of lipid and lipoprotein levels in late onset neonatal sepsis. Scand J Infect Dis 2009; 41 (04) 263-267
    CrossrefPubMedGoogle Scholar
  • 10 Annagür A, Örs R, Altunhan H. , et al. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis. Pediatr Int 2015; 57 (04) 608-613
    CrossrefPubMedGoogle Scholar
  • 11 Tulenko TN, Sumner AE. The physiology of lipoproteins. J Nucl Cardiol 2002; 9 (06) 638-649
    CrossrefPubMedGoogle Scholar
  • 12 Mineo C, Shaul PW. Novel biological functions of high-density lipoprotein cholesterol. Circ Res 2012; 111 (08) 1079-1090
    CrossrefPubMedGoogle Scholar
  • 13 Hodge AM, Jenkins AJ, English DR, O'Dea K, Giles GG. NMR-determined lipoprotein subclass profile predicts type 2 diabetes. Diabetes Res Clin Pract 2009; 83 (01) 132-139
    CrossrefPubMedGoogle Scholar
  • 14 Ford MA, McConnell JP, Lavi S. , et al. Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy. Atherosclerosis 2009; 207 (01) 111-115
    CrossrefPubMedGoogle Scholar
  • 15 Kouda K, Nakamura H, Fujita Y. , et al. HDL subclasses are heterogeneous in their associations with body fat, as measured by dual-energy X-ray absorptiometry: the Kitakata Kids Health Study. Clin Chim Acta 2015; 444: 101-105
    CrossrefPubMedGoogle Scholar
  • 16 Okuma H, Okada T, Abe Y. , et al. Abdominal adiposity is associated with high-density lipoprotein subclasses in Japanese schoolchildren. Clin Chim Acta 2013; 425: 80-84
    CrossrefPubMedGoogle Scholar
  • 17 Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002; 51 (06) 1949-1956
    CrossrefPubMedGoogle Scholar
  • 18 Festa A, Williams K, Hanley AJ. , et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005; 111 (25) 3465-3472
    CrossrefPubMedGoogle Scholar
  • 19 Freedman DS, Bowman BA, Srinivasan SR, Berenson GS, Otvos JD. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism 2001; 50 (03) 370-376
    CrossrefPubMedGoogle Scholar
  • 20 Garvey WT, Kwon S, Zheng D. , et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003; 52 (02) 453-462
    CrossrefPubMedGoogle Scholar
  • 21 Goff Jr DC, D'Agostino Jr RB, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54 (02) 264-270
    CrossrefPubMedGoogle Scholar
  • 22 El Harchaoui K, Arsenault BJ, Franssen R. , et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 2009; 150 (02) 84-93
    CrossrefPubMedGoogle Scholar
  • 23 Hodge AM, Jenkins AJ, English DR, O'Dea K, Giles GG. NMR-determined lipoprotein subclass profile is associated with dietary composition and body size. Nutr Metab Cardiovasc Dis 2011; 21 (08) 603-609
    PubMedGoogle Scholar
  • 24 Koba S, Hirano T, Murayama S. , et al. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 2003; 170 (01) 131-140
    CrossrefPubMedGoogle Scholar
  • 25 Kuller L, Arnold A, Tracy R. , et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2002; 22 (07) 1175-1180
    CrossrefPubMedGoogle Scholar
  • 26 Mackey RH, Greenland P, Goff Jr DC, Lloyd-Jones D, Sibley CT, Mora S. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 2012; 60 (06) 508-516
    CrossrefPubMedGoogle Scholar
  • 27 Otvos JD, Collins D, Freedman DS. , et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006; 113 (12) 1556-1563
    CrossrefPubMedGoogle Scholar
  • 28 Pascot A, Lemieux I, Prud'homme D. , et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 2001; 42 (12) 2007-2014
    PubMedGoogle Scholar
  • 29 Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ. ; Pittsburgh Epidemiology of Diabetes Complications Study. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2003; 46 (05) 674-682
    CrossrefPubMedGoogle Scholar
  • 30 St-Pierre AC, Cantin B, Dagenais GR. , et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005; 25 (03) 553-559
    CrossrefPubMedGoogle Scholar
  • 31 Musunuru K, Orho-Melander M, Caulfield MP. , et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol 2009; 29 (11) 1975-1980
    CrossrefPubMedGoogle Scholar
  • 32 Jeyarajah EJ, Cromwell WC, Otvos JD. Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 2006; 26 (04) 847-870
    CrossrefPubMedGoogle Scholar
  • 33 Kraus WE, Houmard JA, Duscha BD. , et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347 (19) 1483-1492
    CrossrefPubMedGoogle Scholar
  • 34 Burdge GC, Powell J, Dadd T, Talbot D, Civil J, Calder PC. Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years. Br J Nutr 2009; 102 (01) 160-165
    CrossrefPubMedGoogle Scholar
  • 35 Tsai MY, Georgopoulos A, Otvos JD. , et al. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load. Clin Chem 2004; 50 (07) 1201-1204
    CrossrefPubMedGoogle Scholar
  • 36 Mesilati-Stahy R, Moallem U, Magen Y, Argov-Argaman N. Altered concentrate to forage ratio in cows ration enhanced bioproduction of specific size subpopulation of milk fat globules. Food Chem 2015; 179: 199-205
    CrossrefPubMedGoogle Scholar
  • 37 Skouroliakou M, Konstantinou D, Agakidis C. , et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012; 27 (06) 817-824
    CrossrefPubMedGoogle Scholar
  • 38 Spiegler J, Preuß M, Gebauer C, Bendiks M, Herting E, Göpel W. ; German Neonatal Network (GNN); German Neonatal Network GNN. Does breastmilk influence the development of bronchopulmonary dysplasia?. J Pediatr 2016; 169: 76-80.e4
    CrossrefPubMedGoogle Scholar
  • 39 Martin CR, Dasilva DA, Cluette-Brown JE. , et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr 2011; 159 (05) 743-749.e1 , 2
    CrossrefPubMedGoogle Scholar
  • 40 Collins CT, Makrides M, McPhee AJ. , et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N Engl J Med 2017; 376 (13) 1245-1255
    CrossrefPubMedGoogle Scholar
  • 41 Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?. Atherosclerosis 2015; 242 (02) 399-406
    CrossrefPubMedGoogle Scholar
  • 42 Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43 (09) 1363-1379
    CrossrefPubMedGoogle Scholar
  • 43 Imaizumi S, Navab M, Morgantini C. , et al. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J 2011; 75 (07) 1533-1538
    CrossrefPubMedGoogle Scholar
  • 44 Kaseda R, Jabs K, Hunley TE. , et al. Dysfunctional high-density lipoproteins in children with chronic kidney disease. Metabolism 2015; 64 (02) 263-273
    CrossrefPubMedGoogle Scholar
  • 45 Ross DJ, Hough G, Hama S. , et al. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Pulm Circ 2015; 5 (04) 640-648
    CrossrefPubMedGoogle Scholar
  • 46 Ginsburg BE, Zetterström R. Serum cholesterol concentrations in newborn infants with gestational ages of 28-42 weeks. Acta Paediatr Scand 1980; 69 (05) 587-592
    CrossrefPubMedGoogle Scholar
  • 47 Decsi T, Molnár D, Klujber L. Lipid levels in very low birthweight preterm infants. Acta Paediatr Scand 1990; 79 (6-7): 577-580
    CrossrefPubMedGoogle Scholar
  • 48 Decsi T, Fekete M, Szász M, Burus I. Lipid and apolipoprotein levels and enteral nutrition in very low-birth-weight preterm infants. Acta Paediatr 1993; 82 (08) 663-665
    CrossrefPubMedGoogle Scholar
  • 49 Morillas JM, Moltó L, Robles R, Gil A, Sánchez-Pozo A. Lipoproteins in preterm and small-for-gestational-age infants during the first week of life. Acta Paediatr 1992; 81 (10) 774-778
    CrossrefPubMedGoogle Scholar
  • 50 Nagano N, Okada T, Yonezawa R. , et al. Early postnatal changes of lipoprotein subclass profile in late preterm infants. Clin Chim Acta 2012; 413 (1-2): 109-112
    CrossrefPubMedGoogle Scholar
  • 51 Gunes T, Koklu E, Ozturk MA. Maternal and cord serum lipid profiles of preterm infants with respiratory distress syndrome. J Perinatol 2007; 27 (07) 415-421
    CrossrefPubMedGoogle Scholar
  • 52 Sharma D, Nkembi AS, Aubry E. , et al. Maternal PUFA ω-3 supplementation prevents neonatal lung injuries induced by hyperoxia in newborn rats. Int J Mol Sci 2015; 16 (09) 22081-22093
    CrossrefPubMedGoogle Scholar
  • 53 Genzel-Boroviczény O, Göbel Y, Koletzko B. Effect of early enteral feeding on apolipoprotein AI levels and high-density lipoprotein heterogeneity in preterm infants. Ann Nutr Metab 2002; 46 (3-4): 121-127
    CrossrefPubMedGoogle Scholar
  • 54 Rochow N, Möller S, Fusch G, Drogies T, Fusch C. Levels of lipids in preterm infants fed breast milk. Clin Nutr 2010; 29 (01) 94-99
    CrossrefPubMedGoogle Scholar
  • 55 Fujita H, Okada T, Inami I. , et al. Low-density lipoprotein profile changes during the neonatal period. J Perinatol 2008; 28 (05) 335-340
    CrossrefPubMedGoogle Scholar
  • 56 Owen CG, Whincup PH, Odoki K, Gilg JA, Cook DG. Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics 2002; 110 (03) 597-608
    CrossrefPubMedGoogle Scholar
  • 57 Owen CG, Whincup PH, Kaye SJ. , et al. Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr 2008; 88 (02) 305-314
    CrossrefPubMedGoogle Scholar
  • 58 Wang Y, Feng Y, Lu LN. , et al. The effects of different lipid emulsions on the lipid profile, fatty acid composition, and antioxidant capacity of preterm infants: a double-blind, randomized clinical trial. Clin Nutr 2016; 35 (05) 1023-1031
    CrossrefPubMedGoogle Scholar
  • 59 German JB, Dillard CJ. Saturated fats: what dietary intake?. Am J Clin Nutr 2004; 80 (03) 550-559
    CrossrefPubMedGoogle Scholar
  • 60 Astrup A, Dyerberg J, Elwood P. , et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?. Am J Clin Nutr 2011; 93 (04) 684-688
    CrossrefPubMedGoogle Scholar
  • 61 Zock PL, Blom WA, Nettleton JA, Hornstra G. Progressing insights into the role of dietary fats in the prevention of cardiovascular disease. Curr Cardiol Rep 2016; 18 DOI: 10.1007/s11886-016-0793-y.
    CrossrefPubMedGoogle Scholar